Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat Shock Protein gp96 (gp96), also known as grp94, endoplasmin, ERp99, or HSP90B1, is a member of the HSP90 family of molecular chaperones primarily localized in the endoplasmic reticulum (ER). It functions as a dimeric glycoprotein that assists in the folding, maturation, and quality control of newly synthesized proteins within the ER. gp96 binds peptides noncovalently, a property crucial for its role in antigen presentation and immune activation. It plays a pivotal role in both innate and adaptive immunity by chaperoning antigenic peptides for cross-presentation and activating dendritic cells. Dysregulation is implicated in various cancers, and it is explored as a target for cancer immunotherapy.
gp96-peptide complexes are used in autologous cancer vaccines to stimulate anti-tumor immunity by presenting tumor-specific antigens to T cells, leading to cytotoxic T-cell responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat Shock Protein gp96 (gp96).